POLYPID LTD (PYPD) Fundamental Analysis & Valuation
NASDAQ:PYPD • IL0011326795
Current stock price
4.54 USD
-0.15 (-3.2%)
At close:
4.52 USD
-0.02 (-0.44%)
After Hours:
This PYPD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. PYPD Profitability Analysis
1.1 Basic Checks
- PYPD had negative earnings in the past year.
- In the past year PYPD has reported a negative cash flow from operations.
- In the past 5 years PYPD always reported negative net income.
- PYPD had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- PYPD has a Return On Assets of -153.18%. This is amonst the worse of the industry: PYPD underperforms 85.86% of its industry peers.
- PYPD has a Return On Equity of -311.39%. This is in the lower half of the industry: PYPD underperforms 79.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -153.18% | ||
| ROE | -311.39% | ||
| ROIC | N/A |
ROA(3y)-141.17%
ROA(5y)-134.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PYPD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. PYPD Health Analysis
2.1 Basic Checks
- The number of shares outstanding for PYPD has been increased compared to 1 year ago.
- The number of shares outstanding for PYPD has been increased compared to 5 years ago.
- Compared to 1 year ago, PYPD has an improved debt to assets ratio.
2.2 Solvency
- PYPD has an Altman-Z score of -18.66. This is a bad value and indicates that PYPD is not financially healthy and even has some risk of bankruptcy.
- PYPD has a worse Altman-Z score (-18.66) than 83.77% of its industry peers.
- PYPD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -18.66 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- PYPD has a Current Ratio of 1.97. This is a normal value and indicates that PYPD is financially healthy and should not expect problems in meeting its short term obligations.
- PYPD has a Current ratio of 1.97. This is in the lower half of the industry: PYPD underperforms 64.40% of its industry peers.
- A Quick Ratio of 1.82 indicates that PYPD should not have too much problems paying its short term obligations.
- PYPD has a Quick ratio of 1.82. This is in the lower half of the industry: PYPD underperforms 60.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.82 |
3. PYPD Growth Analysis
3.1 Past
- PYPD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.16%, which is quite impressive.
EPS 1Y (TTM)54.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, PYPD will show a very strong growth in Earnings Per Share. The EPS will grow by 30.70% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.45%
EPS Next 2Y25.8%
EPS Next 3Y27.95%
EPS Next 5Y30.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. PYPD Valuation Analysis
4.1 Price/Earnings Ratio
- PYPD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year PYPD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as PYPD's earnings are expected to grow with 27.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.8%
EPS Next 3Y27.95%
5. PYPD Dividend Analysis
5.1 Amount
- No dividends for PYPD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PYPD Fundamentals: All Metrics, Ratios and Statistics
4.54
-0.15 (-3.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-11 2026-02-11/bmo
Earnings (Next)05-13 2026-05-13
Inst Owners25.91%
Inst Owner Change-95.08%
Ins Owners15.53%
Ins Owner Change0%
Market Cap86.62M
Revenue(TTM)N/A
Net Income(TTM)-34.17M
Analysts82
Price Target12.5 (175.33%)
Short Float %0.32%
Short Ratio0.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.29%
Min EPS beat(2)-21.99%
Max EPS beat(2)30.58%
EPS beat(4)2
Avg EPS beat(4)-4.31%
Min EPS beat(4)-39.67%
Max EPS beat(4)30.58%
EPS beat(8)4
Avg EPS beat(8)-6%
EPS beat(12)6
Avg EPS beat(12)1.33%
EPS beat(16)10
Avg EPS beat(16)3.72%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-0.77%
EPS NQ rev (3m)-63.52%
EPS NY rev (1m)3.8%
EPS NY rev (3m)-16.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 7.89 | ||
| P/tB | 7.89 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.26
EYN/A
EPS(NY)-1.5
Fwd EYN/A
FCF(TTM)-1.47
FCFYN/A
OCF(TTM)-1.46
OCFYN/A
SpS0
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -153.18% | ||
| ROE | -311.39% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-141.17%
ROA(5y)-134.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 14.4% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | -18.66 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9.95%
Cap/Depr(5y)73.87%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.39%
EPS Next Y33.45%
EPS Next 2Y25.8%
EPS Next 3Y27.95%
EPS Next 5Y30.7%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.94%
OCF growth 3YN/A
OCF growth 5YN/A
POLYPID LTD / PYPD Fundamental Analysis FAQ
What is the fundamental rating for PYPD stock?
ChartMill assigns a fundamental rating of 2 / 10 to PYPD.
Can you provide the valuation status for POLYPID LTD?
ChartMill assigns a valuation rating of 1 / 10 to POLYPID LTD (PYPD). This can be considered as Overvalued.
What is the profitability of PYPD stock?
POLYPID LTD (PYPD) has a profitability rating of 0 / 10.
Can you provide the financial health for PYPD stock?
The financial health rating of POLYPID LTD (PYPD) is 5 / 10.